Exelixis, Inc. has appointed Arthur DeCillis, M.D. to the position of vice president, clinical research, and Anne Champsaur, M.D. to the position of vice president, drug safety. Both appointees will report to Gisela M. Schwab, M.D., senior vice president and chief medical officer. “With 14 compounds in clinical development, and more expected as we move forward, effective management of our clinical pipeline is critical for our success,” said Dr. Schwab. “Drs. DeCillis and Cha...